Core Viewpoint - Meili Tianyuan Medical Health (02373) announced that non-executive director Li Fangyu has increased her equity in the company by 52,000 shares, representing approximately 0.02% of the total issued shares as of the announcement date, reflecting her strong confidence in the company's future development [1] Group 1: Shareholder Actions - Li Fangyu has acquired a total of 114,500 shares from December 1 to the announcement date, indicating her commitment to the company's growth [1] - The company repurchased 74,500 shares on December 3, with a total transaction amount of approximately HKD 1.94285 million, at an average price of HKD 26.08 per share [1] - From October 15 to the announcement date, the company has repurchased a total of 849,500 shares for approximately HKD 24.636 million [1] Group 2: Management Perspective - The board believes that the current share price does not reflect the intrinsic value and actual business prospects of the company [1] - The board is confident that the share repurchase demonstrates management's commitment to the long-term value of the enterprise, which is beneficial for enhancing the company's market value and shareholder return capabilities [1] - The share repurchase aligns with the overall interests of the company and its shareholders [1]
美丽田园医疗健康获非执行董事李方雨增持5.2万股